The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...

In the trial, people with diabetic macular edema who received ... The most common ocular side effects included conjunctival hemorrhage, eye pain, vitreous floaters, and increased intraocular ...

Diseases causing traction RD include proliferative vitreoretinopathy, proliferative diabetic retinopathy ... Note the small amount of adjacent vitreous hemorrhage. Diagram depicting a single ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

People who've had a cataract (cloudy lens in their eye) removed, have inflammation inside the eye, and those who have diabetes (who either don't ... Bleeding can be a sign of a vitreous hemorrhage.

Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME) – ...

Duravyu at two dose levels met its primary endpoint in the treatment of diabetic macular edema in a phase 2 clinical trial, according to a press release from EyePoint Pharmaceuticals. The FDA has ...

Feb. 4, 2025 — Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, ... Gut Microbes May Mediate ...

Patients requiring vitrectomy for macular hole, macular pucker, and diabetic retinopathy often have coexisting cataract. Cataract formation is one of the most common sequelae following vitrectomy.

Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

Andrew Iwach, MD, co-founder of the Glaucoma 360 meeting shares that value this meeting has for residents and fellows as they embark on their careers and the future additions to the meeting that will ...